These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 15460529)

  • 1. E-test method for detecting antibiotic synergy against Pseudomonas aeruginosa from neutropenic patients: a cost-effective approach.
    Di Bonaventura G; Picciani C; Spedicato I; Piccolomini R
    New Microbiol; 2004 Jul; 27(3):263-72. PubMed ID: 15460529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergy tests by E test and checkerboard methods of antimicrobial combinations against Brucella melitensis.
    Orhan G; Bayram A; Zer Y; Balci I
    J Clin Microbiol; 2005 Jan; 43(1):140-3. PubMed ID: 15634962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of the synergy of antibiotic combinations by an overlay inoculum susceptibility disc method.
    Chinwuba ZG; Chiori CO; Ghobashy AA; Okore VC
    Arzneimittelforschung; 1991 Feb; 41(2):148-50. PubMed ID: 1904228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative bactericidal activity of beta-lactam-aminoglycoside combinations against Pseudomonas aeruginosa].
    Cluzel M; Chanal M; Sirot J; Cluzel R
    Nouv Presse Med; 1982 Nov; 11(46):3400-4. PubMed ID: 6818523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the E test for the assessment of synergy of antibiotic combinations against multiresistant Pseudomonas aeruginosa isolates from cystic fibrosis patients.
    Balke B; Hogardt M; Schmoldt S; Hoy L; Weissbrodt H; Häussler S
    Eur J Clin Microbiol Infect Dis; 2006 Jan; 25(1):25-30. PubMed ID: 16402226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro Etest synergy of doripenem with amikacin, colistin, and levofloxacin against Pseudomonas aeruginosa with defined carbapenem resistance mechanisms as determined by the Etest method.
    He W; Kaniga K; Lynch AS; Flamm RK; Davies TA
    Diagn Microbiol Infect Dis; 2012 Dec; 74(4):417-9. PubMed ID: 22995366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of oxygen limitation on the in vitro activity of levofloxacin and other antibiotics administered by the aerosol route against Pseudomonas aeruginosa from cystic fibrosis patients.
    King P; Citron DM; Griffith DC; Lomovskaya O; Dudley MN
    Diagn Microbiol Infect Dis; 2010 Feb; 66(2):181-6. PubMed ID: 19828274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic synergy: clinical applications and an in vitro study of cefotaxime-aminoglycoside combinations.
    Faris HM; Dreskin RB
    J S C Med Assoc; 1983 May; 79(5):275-7. PubMed ID: 6308348
    [No Abstract]   [Full Text] [Related]  

  • 10. Post-antibiotic effect of levofloxacin and tobramycin alone or in combination with cefepime against Pseudomonas aeruginosa.
    Ozbek B; Otuk G
    Chemotherapy; 2009; 55(6):446-50. PubMed ID: 19996590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of the checkerboard and E-test methods used for the analysis of two antibiotics combination].
    Grzybowska W; Banaszczyk-Ruś M; Tyski S
    Med Dosw Mikrobiol; 2005; 57(1):65-75. PubMed ID: 16130296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An in vitro investigation of synergy or antagonism between antimicrobial combinations against isolates from bacterial keratitis.
    Sueke H; Kaye SB; Neal T; Hall A; Tuft S; Parry CM
    Invest Ophthalmol Vis Sci; 2010 Aug; 51(8):4151-5. PubMed ID: 20335613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of doripenem with and without levofloxacin, amikacin, and colistin against Pseudomonas aeruginosa and Acinetobacter baumannii.
    Pankuch GA; Seifert H; Appelbaum PC
    Diagn Microbiol Infect Dis; 2010 Jun; 67(2):191-7. PubMed ID: 20338710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic in vitro and in vivo activities of ampicillin and aminoglycoside combinations against antibiotic-resistant Pseudomonas aeruginosa strains.
    Elkhouly AE; el-Sokkary MA; el-Emam MA
    Chemioterapia; 1987 Jun; 6(2 Suppl):125-8. PubMed ID: 3151331
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions.
    Hill D; Rose B; Pajkos A; Robinson M; Bye P; Bell S; Elkins M; Thompson B; Macleod C; Aaron SD; Harbour C
    J Clin Microbiol; 2005 Oct; 43(10):5085-90. PubMed ID: 16207967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic potential of ceftazidime plus amikacin or levofloxacin against Pseudomonas aeruginosa as determined using a checkerboard and a disk diffusion technique.
    Montanari MP; Piccoli L; Mingoia M; Marchetti F; Varaldo PE
    Diagn Microbiol Infect Dis; 2005 Oct; 53(2):157-60. PubMed ID: 16168614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of various antibiotic combinations using the E-Test method in multiresistant Pseudomonas aeruginosa strains.
    Kocazeybek B; Arabaci U; Erentürk S; Akdur H
    Chemotherapy; 2002 Mar; 48(1):31-5. PubMed ID: 11901254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical utility of synergy testing for multidrug-resistant Pseudomonas aeruginosa isolated from patients with cystic fibrosis: 'the motion for'.
    Saiman L
    Paediatr Respir Rev; 2007 Sep; 8(3):249-55. PubMed ID: 17868923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of breakpoint combination sensitivity testing as a simple and convenient method to evaluate the combined effects of ceftazidime and tobramycin on Pseudomonas aeruginosa and Burkholderia cepacia complex isolates in vitro.
    Tunney MM; Scott EM
    J Microbiol Methods; 2004 Apr; 57(1):107-14. PubMed ID: 15003693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 'Break-point Checkerboard Plate' for screening of appropriate antibiotic combinations against multidrug-resistant Pseudomonas aeruginosa.
    Tateda K; Ishii Y; Matsumoto T; Yamaguchi K
    Scand J Infect Dis; 2006; 38(4):268-72. PubMed ID: 16709527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.